Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · IEX Real-Time Price · USD
1.63
-0.01 (-0.61%)
At close: May 27, 2022 4:00 PM
1.70
0.07 (4.29%)
After-hours:May 27, 2022 4:11 PM EDT
Cash Flow Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.61 | -1.82 | -3.42 | -4.43 | -7.05 | -25.88 | -13.88 | -4.42 | -1.08 | -0.01 | Upgrade |
Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade |
Share-Based Compensation | 0.21 | 0 | 0.15 | -0.61 | -0.58 | 9.55 | 3.7 | 0.26 | 0 | 0 | Upgrade |
Other Operating Activities | 0.18 | 1.4 | 0.02 | 0.93 | 4.31 | 9 | 6.63 | 1.41 | 0.56 | -0 | Upgrade |
Operating Cash Flow | -1.23 | -0.43 | -3.25 | -4.1 | -3.33 | -7.33 | -3.55 | -2.76 | -0.53 | -0.01 | Upgrade |
Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0.01 | 0 | 0 | Upgrade |
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | Upgrade |
Investing Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0.03 | 0 | 0 | Upgrade |
Share Issuance / Repurchase | 6.86 | 0 | 0 | 4.37 | 0.7 | 3.75 | 0 | 0.48 | 0 | 0 | Upgrade |
Debt Issued / Paid | 1.05 | 0.4 | 2.32 | 0 | 2.7 | 3.08 | 2 | 4.91 | 0.52 | 0 | Upgrade |
Other Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | Upgrade |
Financing Cash Flow | 7.9 | 0.4 | 2.32 | 4.37 | 3.4 | 6.83 | 2 | 5.39 | 0.52 | 0.01 | Upgrade |
Net Cash Flow | 6.68 | -0.02 | -0.93 | 0.27 | 0.07 | -0.49 | -1.55 | 2.66 | -0 | 0 | Upgrade |
Free Cash Flow | -1.23 | -0.43 | -3.25 | -4.1 | -3.33 | -7.33 | -3.55 | -2.77 | -0.53 | -0.01 | Upgrade |
Free Cash Flow Per Share | -0.27 | -0.15 | -1.11 | -2.04 | -2.14 | -4.87 | -3.12 | -4.63 | -1.20 | -0.03 | Upgrade |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).